PROVIDER PROFILE · NPI 1518006543

Mohammad FekrazadMD

HematologyValencia, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

790

Beneficiaries

—

Total drug cost

$1.8M

Distinct drugs

Brand share

34.6%

Top prescribed drugs

Anastrozole129 claims

Rivaroxaban96 claims

Prednisone74 claims

Abiraterone Acetate60 claims

Hydroxyurea49 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Mohammad Fekrazad's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
ANTELOPE VALLEY HEALTH CARE DISTRICT	106	1,419
Nimit Sudan Hematology-Oncology · Encino, CA	72	1,476
Unilab Corporation Clinical Laboratory · West Hills, CA	32	532
Khalid Javeri Diagnostic Radiology · Santa Monica, CA	30	129
Viken Manjikian Diagnostic Radiology · Eden Prairie, MN	24	107
Yih-Dar Nien General Surgery · Encino, CA	21	182
LASK, DAVID	15	60
Vivaik Tyagi Gastroenterology · Lancaster, CA	14	129
RIDGECREST REGIONAL HOSPITAL	12	175
Olga Lyass Diagnostic Radiology · Lancaster, CA	11	28

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history